By the time you are reading this month’s column, states will have submitted their responses to HHS’s request for proposals (RFP) in support of the Rural Health Transformation Program.

Michael D. Hogue, PharmD, FAPhA, FNAP, FFIP, Executive vice president and CEO of APhA

While walking to the office, I pass the Department of Commerce building, upon which is etched a phrase by Thomas Jefferson: “Cultivate Peace and Commerce.”

Michael D. Hogue, PharmD, FAPhA, FNAP, FFIP, Executive vice president and CEO of APhA

On July 4, 2025, President Donald Trump signed into law H.R. 1, the One Big Beautiful Bill Act.

Michael D. Hogue, PharmD, FAPhA, FNAP, FFIP, Executive vice president and CEO of APhA

Nearly everyone can agree that doing business in Washington, DC, as a professional association is radically different than what we’ve experienced in the past two decades.

Michael D. Hogue, PharmD, FAPhA, FNAP, FFIP, Executive vice president and CEO of APhA

When I was in pharmacy school, I enrolled in stand-alone coursework and a clinical rotation in drug information. Domingo Martinez was in his final year of teaching at Samford University, and a new professor, Mike Kendrach, had started.

Michael D. Hogue, PharmD, FAPhA, FNAP, FFIP, Executive vice president and CEO of APhA